Dolobid
- Product NDC
- 74157-101
- 11-digit product format
- 741570101
- Labeler code
- 74157
- Product ID
- 74157-101_4081e337-1003-6e39-e063-6294a90a4698
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diflunisal
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- INA Pharmaceutics Inc
- Application
- ANDA202845
- Marketing category
- ANDA
- Marketing start
- 2024-08-19
- Substance
- DIFLUNISAL
- Active strength
- 375 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dolobid
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DIFLUNISAL | 375 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 7C546U4DEN |
| Rxcui | 105823, 197602, 249400, 2691103 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 74157-101-60 | Dolobid | 60 in 1 BOTTLE | TABLET, FILM COATED | 60 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 74157-101 | DOLOBID (DIFLUNISAL) TABLET, FILM COATED [INA PHARMACEUTICS INC] | 3 | Current NDC, 1 package rows | 20240829_725234b2-0e23-45c3-a42d-eb4e62273f9b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 74157-101-60 | 74157010160 | 60 TABLET, FILM COATED in 1 BOTTLE (74157-101-60) | 2024-08-19 | No | No | Current |